Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ludovic Samalin, Aurore Tremey & Pierre-Michel Llorca. (2014) Quetiapine extended release for the treatment of bipolar disorder. Expert Review of Neurotherapeutics 14:9, pages 987-1005.
Read now
Read now
Ross J. Baldessarini, Eduard Vieta, Joseph R. Calabrese, Mauricio Tohen & Charles L. Bowden. (2010) Bipolar Depression: Overview and Commentary. Harvard Review of Psychiatry 18:3, pages 143-157.
Read now
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Hans-Jürgen Möller & Siegfried Kasper. (2010) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. The World Journal of Biological Psychiatry 11:2, pages 81-109.
Read now
Read now
Articles from other publishers (41)
. (2023) Assessment and Management of Bipolar Disorder. FOCUS 21:4, pages 399-400.
Crossref
Crossref
Holly A. SwartzTrisha Suppes. (2023) Bipolar II Disorder: Understudied and Underdiagnosed. FOCUS 21:4, pages 354-362.
Crossref
Crossref
Masaki Kato, Takahiro Masuda, Fumiya Sano & Tadafumi Kato. (2023) The efficacy and safety of lurasidone in bipolar I depression with and without rapid cycling: A pooled post-hoc analysis of two randomized, placebo-controlled trials. Journal of Affective Disorders 337, pages 150-158.
Crossref
Crossref
Roger S. McIntyre, Martin Alda, Ross J. Baldessarini, Michael Bauer, Michael Berk, Christoph U. Correll, Andrea Fagiolini, Kostas Fountoulakis, Mark A. Frye, Heinz Grunze, Lars V. Kessing, David J. Miklowitz, Gordon Parker, Robert M. Post, Alan C. Swann, Trisha Suppes, Eduard Vieta, Allan Young & Mario Maj. (2022) The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry 21:3, pages 364-387.
Crossref
Crossref
Evangelos Karamatskos & Jürgen Gallinat. (2022) Bipolar-II-Störungen. Fortschritte der Neurologie · Psychiatrie 90:04, pages 173-190.
Crossref
Crossref
Joseph R. CalabreseSuresh DurgamAndrew SatlinKimberly E. VanoverRobert E. DavisRichard ChenSusan G. KozauerSharon MatesGary S. Sachs. (2021) Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial. American Journal of Psychiatry 178:12, pages 1098-1106.
Crossref
Crossref
Evangelos Karamatskos & Jürgen Gallinat. (2021) Bipolar-II-Störungen. PSYCH up2date 15:05, pages 393-413.
Crossref
Crossref
Sheng-Yu Lee, Tzu-Yun Wang, Ru-Band Lu, Liang-Jen Wang, Sung-Chou Li, Chi-Ying Tu, Cheng-Ho Chang, Yung-Chih Chiang & Kuo-Wang Tsai. (2021) Identification of potential plasma protein biomarkers for bipolar II disorder: a preliminary/exploratory study. Scientific Reports 11:1.
Crossref
Crossref
Laura Weiss Roberts, Robert E. Hales & Stuart C. YudofskyShefali Miller, Michael Ostacher & Trisha Suppes. 2019. The American Psychiatric Association Publishing Textbook of Psychiatry. The American Psychiatric Association Publishing Textbook of Psychiatry.
Laura Weiss Roberts, Robert E. Hales & Stuart C. YudofskyShefali Miller, Michael Ostacher & Trisha Suppes. 2019. The American Psychiatric Association Publishing Textbook of Psychiatry. The American Psychiatric Association Publishing Textbook of Psychiatry.
William V. Bobo. (2017) The Diagnosis and Management of Bipolar I and II Disorders: Clinical Practice Update. Mayo Clinic Proceedings 92:10, pages 1532-1551.
Crossref
Crossref
Konstantinos N. Fountoulakis, Lakshmi Yatham, Heinz Grunze, Eduard Vieta, Allan Young, Pierre Blier, Siegfried Kasper & Hans Jurgen Moeller. (2016) The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm. International Journal of Neuropsychopharmacology, pages pyw100.
Crossref
Crossref
Dong Yeon Park, Kathryn C. Goffin, Saloni Shah, Laura D. Yuen, Jessica N. Holtzman, Farnaz Hooshmand, Shefali Miller, Po W. Wang & Terence A. Ketter. (2016) Differential prevalence and demographic and clinical correlates of second-generation antipsychotic use in bipolar I versus bipolar II disorder. Journal of Psychiatric Research 76, pages 52-58.
Crossref
Crossref
Kostas N. FountoulakisKostas N. Fountoulakis. 2015. Bipolar Disorder. Bipolar Disorder
461
625
.
L. Renata Thronson & Genevieve L. Pagalilauan. (2014) Psychopharmacology. Medical Clinics of North America 98:5, pages 927-958.
Crossref
Crossref
Allan H Young, Joseph R Calabrese, Urban Gustafsson, Michael Berk, Susan L McElroy, Michael E Thase, Trisha Suppes & Willie Earley. (2013) Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies. International Journal of Bipolar Disorders 1:1.
Crossref
Crossref
Ya-Mei Bai, Ching-Jui Chang, Shang-Ying Tsai, Yi-Chyan Chen, Mei-Chun Hsiao, Cheng-Ta Li, Peichi Tu, Shang-Wen Chang, Winston W. Shen & Tung-Ping Su. (2013) Taiwan consensus of pharmacological treatment for bipolar disorder. Journal of the Chinese Medical Association 76:10, pages 547-556.
Crossref
Crossref
Trisha Suppes, Terence A. Ketter, Iola S. Gwizdowski, Ellen B. Dennehy, Shelley J. Hill, E. Grace Fischer, Diane E. Snow, Robert Gonzalez, Suresh Sureddi, Geetha Shivakumar & Victoria E. Cosgrove. (2013) First controlled treatment trial of bipolar II hypomania with mixed symptoms: Quetiapine versus placebo. Journal of Affective Disorders 150:1, pages 37-43.
Crossref
Crossref
David V. Sheehan, Kathy Harnett-Sheehan, Rosario B. Hidalgo, Juris Janavs, Susan L. McElroy, Darlene Amado & Trisha Suppes. (2013) Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient. Journal of Affective Disorders 145:1, pages 83-94.
Crossref
Crossref
Matthew J. Taylor & John R. Geddes. 2012. Essential Evidence-Based Psychopharmacology. Essential Evidence-Based Psychopharmacology
39
52
.
Konstantinos N. Fountoulakis, Siegfried Kasper, Ole Andreassen, Pierre Blier, Ahmed Okasha, Emanuel Severus, Marcio Versiani, Rajiv Tandon, Hans-Jürgen Möller & Eduard Vieta. (2012) Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience 262:S1, pages 1-48.
Crossref
Crossref
Mark Sanford & Gillian M. Keating. (2012) Quetiapine. CNS Drugs 26:5, pages 435-460.
Crossref
Crossref
Gin S Malhi, Danielle M Bargh, Emma Cashman, Mark A Frye & Michael Gitlin. (2012) The clinical management of bipolar disorder complexity using a stratified model. Bipolar Disorders 14, pages 66-89.
Crossref
Crossref
Konstantinos N. Fountoulakis, John R. Kelsoe & Hagop Akiskal. (2012) Receptor targets for antidepressant therapy in bipolar disorder: An overview. Journal of Affective Disorders 138:3, pages 222-238.
Crossref
Crossref
Eduard Vieta. 2012. Bipolar II Disorder. Bipolar II Disorder
258
261
.
Michael E. Thase. 2012. Bipolar II Disorder. Bipolar II Disorder
254
257
.
Terence A. Ketter & Po W. Wang. 2012. Bipolar II Disorder. Bipolar II Disorder
192
213
.
George Hadjipavlou, David J. Bond & Lakshmi N. Yatham. 2012. Bipolar II Disorder. Bipolar II Disorder
114
125
.
Holly A Swartz, Ellen Frank & Yu Cheng. (2012) A randomized pilot study of psychotherapy and quetiapine for the acute treatment of bipolar II depression. Bipolar Disorders 14:2, pages 211-216.
Crossref
Crossref
Janusz K. Rybakowski. (2012) Bipolarity and inadequate response to antidepressant drugs: Clinical and psychopharmacological perspective. Journal of Affective Disorders 136:1-2, pages e13-e19.
Crossref
Crossref
Kate E. A. Saunders & G. M. Goodwin. 2013. Behavioral Neurobiology of Depression and Its Treatment. Behavioral Neurobiology of Depression and Its Treatment
291
307
.
Mauricio Kunz, Svante Nyberg & Lakshmi N. Yatham. 2011. Bipolar Psychopharmacotherapy. Bipolar Psychopharmacotherapy
193
222
.
Tsuyoshi Kondo. (2011) How can we classify “mood stabilizers” with different properties?. Clinical Neuropsychopharmacology and Therapeutics 2:0, pages 12-23.
Crossref
Crossref
Konstantinos N Fountoulakis, Xenia Gonda, Eduard Vieta & Zoltan Rihmer. (2011) Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?. Annals of General Psychiatry 10:1, pages 8.
Crossref
Crossref
Mario A. Cristancho & Michael E. Thase. (2010) The role of quetiapine extended release in the treatment of bipolar depression. Advances in Therapy 27:11, pages 774-784.
Crossref
Crossref
Ihsan M. Salloum, Luca Pani & Tiffany Cooke. 2010. Bipolar Disorder. Bipolar Disorder
353
366
.
Allan H. Young & Charles B. Nemeroff. 2010. Bipolar Disorder. Bipolar Disorder
294
303
.
Nuria Cruz, Jose Sanchez-Moreno, Ferran Torres, Jose Manuel Goikolea, Marc Valentí & Eduard Vieta. (2009) Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. The International Journal of Neuropsychopharmacology 13:01, pages 5.
Crossref
Crossref
Gin S. Malhi, Danielle Adams, Catherine M. Cahill, Seetal Dodd & Michael Berk. (2009) The Management of Individuals with Bipolar Disorder. Drugs 69:15, pages 2063-2101.
Crossref
Crossref
Philip B MitchellColleen K LooMichael Breakspear. (2009) Recent progress in the pharmacotherapy of bipolar disorder. Future Neurology 4:4, pages 493-508.
Crossref
Crossref
Lakshmi N Yatham, Sidney H Kennedy, Ayal Schaffer, Sagar V Parikh, Serge Beaulieu, Claire O'Donovan, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Arun Ravindran, L Trevor Young, Allan H Young, Martin Alda, Roumen Milev, Eduard Vieta, Joseph R Calabrese, Michael Berk, Kyooseob Ha & Flávio Kapczinski. (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders 11:3, pages 225-255.
Crossref
Crossref